Recurrent granulibacter bethesdensis infections and chronic granulomatous disease

David E. Greenberg, Adam R. Shoffner, Adrian M. Zelazny, Michael E. Fenster, Kol A. Zarember, Frida Stock, Li Ding, Kimberly R. Marshall-Batty, Richard L. Wasserman, David F. Welch, Kishore Kanakabandi, Dan E. Sturdevant, Kimmo Virtaneva, Stephen F. Porcella, Patrick R. Murray, Harry L. Malech, Steven M. Holland

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Chronic granulomatous disease (CGD) is characterized by frequent infections, most of which are curable. Granulibacter bethesdensis is an emerging pathogen in patients with CGD that causes fever and necrotizing lymphadenitis. However, unlike typical CGD organisms, this organism can cause relapse after clinical quiescence. To better define whether infections were newly acquired or recrudesced, we use comparative bacterial genomic hybridization to characterize 11 isolates obtained from 5 patients with CGD from orth and entral America. Genomic typing showed that 3 atients had recurrent infection months to years after apparent linical cure. Two patients were infected with the same train as previously isolated, and 1 was infected with a enetically istinct strain. This organism is multidrug resistant, nd therapy required surgery and combination ntimicrobial drugs, including long-term ceftriaxone. G. bethesdensis causes necrotizing lymphadenitis in CGD, which may recur or relapse.

Original languageEnglish (US)
Pages (from-to)1341-1348
Number of pages8
JournalEmerging Infectious Diseases
Volume16
Issue number9
DOIs
StatePublished - 2010

Fingerprint

Chronic Granulomatous Disease
Infection
Lymphadenitis
Recurrence
Comparative Genomic Hybridization
Ceftriaxone
Drug Combinations
Fever

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases
  • Epidemiology

Cite this

Greenberg, D. E., Shoffner, A. R., Zelazny, A. M., Fenster, M. E., Zarember, K. A., Stock, F., ... Holland, S. M. (2010). Recurrent granulibacter bethesdensis infections and chronic granulomatous disease. Emerging Infectious Diseases, 16(9), 1341-1348. https://doi.org/10.3201/eid1609.091800

Recurrent granulibacter bethesdensis infections and chronic granulomatous disease. / Greenberg, David E.; Shoffner, Adam R.; Zelazny, Adrian M.; Fenster, Michael E.; Zarember, Kol A.; Stock, Frida; Ding, Li; Marshall-Batty, Kimberly R.; Wasserman, Richard L.; Welch, David F.; Kanakabandi, Kishore; Sturdevant, Dan E.; Virtaneva, Kimmo; Porcella, Stephen F.; Murray, Patrick R.; Malech, Harry L.; Holland, Steven M.

In: Emerging Infectious Diseases, Vol. 16, No. 9, 2010, p. 1341-1348.

Research output: Contribution to journalArticle

Greenberg, DE, Shoffner, AR, Zelazny, AM, Fenster, ME, Zarember, KA, Stock, F, Ding, L, Marshall-Batty, KR, Wasserman, RL, Welch, DF, Kanakabandi, K, Sturdevant, DE, Virtaneva, K, Porcella, SF, Murray, PR, Malech, HL & Holland, SM 2010, 'Recurrent granulibacter bethesdensis infections and chronic granulomatous disease', Emerging Infectious Diseases, vol. 16, no. 9, pp. 1341-1348. https://doi.org/10.3201/eid1609.091800
Greenberg, David E. ; Shoffner, Adam R. ; Zelazny, Adrian M. ; Fenster, Michael E. ; Zarember, Kol A. ; Stock, Frida ; Ding, Li ; Marshall-Batty, Kimberly R. ; Wasserman, Richard L. ; Welch, David F. ; Kanakabandi, Kishore ; Sturdevant, Dan E. ; Virtaneva, Kimmo ; Porcella, Stephen F. ; Murray, Patrick R. ; Malech, Harry L. ; Holland, Steven M. / Recurrent granulibacter bethesdensis infections and chronic granulomatous disease. In: Emerging Infectious Diseases. 2010 ; Vol. 16, No. 9. pp. 1341-1348.
@article{e18e6fae681348e2a8cfcfe1a54bdb92,
title = "Recurrent granulibacter bethesdensis infections and chronic granulomatous disease",
abstract = "Chronic granulomatous disease (CGD) is characterized by frequent infections, most of which are curable. Granulibacter bethesdensis is an emerging pathogen in patients with CGD that causes fever and necrotizing lymphadenitis. However, unlike typical CGD organisms, this organism can cause relapse after clinical quiescence. To better define whether infections were newly acquired or recrudesced, we use comparative bacterial genomic hybridization to characterize 11 isolates obtained from 5 patients with CGD from orth and entral America. Genomic typing showed that 3 atients had recurrent infection months to years after apparent linical cure. Two patients were infected with the same train as previously isolated, and 1 was infected with a enetically istinct strain. This organism is multidrug resistant, nd therapy required surgery and combination ntimicrobial drugs, including long-term ceftriaxone. G. bethesdensis causes necrotizing lymphadenitis in CGD, which may recur or relapse.",
author = "Greenberg, {David E.} and Shoffner, {Adam R.} and Zelazny, {Adrian M.} and Fenster, {Michael E.} and Zarember, {Kol A.} and Frida Stock and Li Ding and Marshall-Batty, {Kimberly R.} and Wasserman, {Richard L.} and Welch, {David F.} and Kishore Kanakabandi and Sturdevant, {Dan E.} and Kimmo Virtaneva and Porcella, {Stephen F.} and Murray, {Patrick R.} and Malech, {Harry L.} and Holland, {Steven M.}",
year = "2010",
doi = "10.3201/eid1609.091800",
language = "English (US)",
volume = "16",
pages = "1341--1348",
journal = "Emerging Infectious Diseases",
issn = "1080-6040",
publisher = "Centers for Disease Control and Prevention (CDC)",
number = "9",

}

TY - JOUR

T1 - Recurrent granulibacter bethesdensis infections and chronic granulomatous disease

AU - Greenberg, David E.

AU - Shoffner, Adam R.

AU - Zelazny, Adrian M.

AU - Fenster, Michael E.

AU - Zarember, Kol A.

AU - Stock, Frida

AU - Ding, Li

AU - Marshall-Batty, Kimberly R.

AU - Wasserman, Richard L.

AU - Welch, David F.

AU - Kanakabandi, Kishore

AU - Sturdevant, Dan E.

AU - Virtaneva, Kimmo

AU - Porcella, Stephen F.

AU - Murray, Patrick R.

AU - Malech, Harry L.

AU - Holland, Steven M.

PY - 2010

Y1 - 2010

N2 - Chronic granulomatous disease (CGD) is characterized by frequent infections, most of which are curable. Granulibacter bethesdensis is an emerging pathogen in patients with CGD that causes fever and necrotizing lymphadenitis. However, unlike typical CGD organisms, this organism can cause relapse after clinical quiescence. To better define whether infections were newly acquired or recrudesced, we use comparative bacterial genomic hybridization to characterize 11 isolates obtained from 5 patients with CGD from orth and entral America. Genomic typing showed that 3 atients had recurrent infection months to years after apparent linical cure. Two patients were infected with the same train as previously isolated, and 1 was infected with a enetically istinct strain. This organism is multidrug resistant, nd therapy required surgery and combination ntimicrobial drugs, including long-term ceftriaxone. G. bethesdensis causes necrotizing lymphadenitis in CGD, which may recur or relapse.

AB - Chronic granulomatous disease (CGD) is characterized by frequent infections, most of which are curable. Granulibacter bethesdensis is an emerging pathogen in patients with CGD that causes fever and necrotizing lymphadenitis. However, unlike typical CGD organisms, this organism can cause relapse after clinical quiescence. To better define whether infections were newly acquired or recrudesced, we use comparative bacterial genomic hybridization to characterize 11 isolates obtained from 5 patients with CGD from orth and entral America. Genomic typing showed that 3 atients had recurrent infection months to years after apparent linical cure. Two patients were infected with the same train as previously isolated, and 1 was infected with a enetically istinct strain. This organism is multidrug resistant, nd therapy required surgery and combination ntimicrobial drugs, including long-term ceftriaxone. G. bethesdensis causes necrotizing lymphadenitis in CGD, which may recur or relapse.

UR - http://www.scopus.com/inward/record.url?scp=77956053139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956053139&partnerID=8YFLogxK

U2 - 10.3201/eid1609.091800

DO - 10.3201/eid1609.091800

M3 - Article

C2 - 20735916

AN - SCOPUS:77956053139

VL - 16

SP - 1341

EP - 1348

JO - Emerging Infectious Diseases

JF - Emerging Infectious Diseases

SN - 1080-6040

IS - 9

ER -